{
  "version": "1.0",
  "type": "rich",
  "provider_name": "TruthFoundry News",
  "provider_url": "https://news.truthfoundry.ai/",
  "title": "Phase I trial shows ERAS-0015 effective for RAS-mutant lung and pancreatic cancer",
  "author_name": "TruthFoundry News Desk",
  "author_url": "https://news.truthfoundry.ai/",
  "html": "<iframe src=\"https://news.truthfoundry.ai/embed/1189ad832d18be7318d42d556491acc4\" title=\"Story card\" width=\"100%\" height=\"260\" style=\"border:0;width:100%;max-width:640px\" loading=\"lazy\"></iframe>",
  "width": 640,
  "height": 260,
  "cache_age": 3600
}